<DOC>
	<DOC>NCT00162305</DOC>
	<brief_summary>The purpose of this clinical research study is to assess the safety of, exposure to, and biological effects of BMS-512148 in stable Type 2 diabetic subjects</brief_summary>
	<brief_title>A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Established diagnosis of Type 2 diabetes mellitus, who are treated with metformin or diet alone (drug naive). Fasting glucose (FG) &lt; 240 mg/dL, while on metformin or antidiabetic diet alone. HbA1c (Hemoglobin A1c) in the range of 6.010.0% Women of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>